Details of the Drug Formulaction

General Information of Drug Formulation (ID: F05253)

• Formulation Name: Darifenacin 7.5 mg tablet
• Company: Actavis Pharma; Warner Chilcott Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Darifenacin	(DMWXLYZ)	Overactive bladder	GC50.0	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Calcium hydrogenphosphate	(E00294)	24441	Diluent
Magnesium stearate	(E00208)	11177	lubricant
Polyethylene glycol 200	(E00648)	Not Available	Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent